- Fla. conference brings together investors and biotechs
About 400 people are anticipated to attend this year's Southeast Bio Investor Forum hosted by BioFlorida in Palm Beach, Fla. The three-day event, which started Tuesday, will continue as scheduled despite some participants being kept away by the effects of superstorm Sandy. Biotech companies will present at the event to attract investment from venture capital firms. Sun-Sentinel (Fort Lauderdale, Fla.) (10/30)        | Accelerate molecular simulations for your drug discovery research, with Accelrys Discovery Studio ® 3.5!
Designed to address the modeling challenges faced by research scientists, Discovery Studio 3.5 is Accelrys' latest, and most complete modeling and simulation solution for small molecules and macromolecules-based drug design. Register for our webinar and learn about Accelrys Discovery Studio. | |
| Health Care & Policy |  |  | | - Cartilage developed from iPS cells in animal study
Duke University researchers created cartilage using induced pluripotent stem cells from mice, according to a study in the journal Proceedings of the National Academy of Sciences. The method could allow for the development of "a continuous supply of cartilage in a dish," said senior author Farshid Guilak. The next step will be to see if the method works using human cells. U.S. News & World Report/HealthDay News (10/29) - Biotech startup raises $16M to develop treatments for skin diseases
San Diego, Calif.-based startup Thesan Pharmaceuticals secured $16 million in a Series A funding round led by Novartis Venture Funds and Novo Ventures. The firm will use the proceeds to develop treatments for inflammatory skin conditions. "Thesan's mission is to develop new chemical entities with novel mechanisms of action in order to substantially improve treatment outcomes for patients with a variety of dermatological diseases," Thesan Executive Chairman and CEO Gordon Foulkes said. MedCityNews.com (10/30)  |
With in-depth industry knowledge, GE Capital, Healthcare Financial Services' dedicated Life Science Finance team has worked with more than 500 companies and provided over $2.5 billion in financing to the market. Stop just banking. And start building. Click here to find out more. | |
| Food & Agriculture | | | | | Industrial & Environmental | | | | - ZeaChem completes Ore. advanced-biofuels plant
ZeaChem has completed construction of its advanced-biofuels plant in Boardman, Ore., and expects production to begin by the end of the year. The facility will use locally grown willow and other biomass. Meanwhile, the company has secured $25 million in new financing from a group of investors including Japan's ITOCHU and Australia-based Macquarie. EthanolProducer.com (10/29)  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| News from BIO | | | | - Are you taking full advantage of your membership?
BIO's cost-savings program, BIO Business Solutions, is helping 2,700 companies nationwide save on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot and Business Wire are just a few of the industry leading providers that offer special pricing through this members-only program. Learn more or enroll here.
| SmartQuote | | | |  | Where there is no imagination there is no horror."
--Sir Arthur Conan Doyle,
Scottish physician and writer  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Tuesday, October 30, 2012
- Monday, October 29, 2012
- Friday, October 26, 2012
- Thursday, October 25, 2012
- Wednesday, October 24, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment